Clinical Trial Update: Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate hyperbaric oxygen therapy for post-COVID-19 syndrome with neurocognitive symptoms at Assaf-Harofeh Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Covid19, Neurocognitive Dysfunction | NA | Status: RECRUITING